Introduction: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe, life-threatening adverse drug reaction that causes multiorgan involvement characterized by rash, fever, lymphadenopathy, and eosinophilia. Only one case of fenofibrate-associated DRESS syndrome has been reported in the literature. Case presentation: A 70-year-old man with hypertension and hypertriglyceridemia presented to the emergency department of a university hospital in Bogotá (Colombia) with a generalized erythematous rash, intermittent fever (38.6°C), diarrhea, nausea, and palpitations over the preceding 3 days. The patient reported initiating fenofibrate (160 mg/day) 2 weeks prior for hypertriglyceridemia management. Admission laboratory tests revealed eosinophilia and elevated transaminases. The patient scored 4 according to RegiSCAR criteria, consistent with a probable case of fenofibrate-associated DRESS syndrome, so he was admitted. The drug was immediately discontinued, and IV methylprednisolone (250 mg/day) was initiated for 3 days, followed by oral prednisolone (1 mg/kg/day) with a planned taper. On hospital day 7, following favorable clinical progress (progressive improvement of skin lesions and normalization of eosinophil count), he was discharged with instructions to continue oral prednisolone on a gradual 8-week taper, during which no relapses or adverse events occurred. Conclusion: This case highlights the importance of timely recognition of DRESS syndrome clinical manifestations and prompt identification of the suspected drug, even when rarely implicated, such as fenofibrate. It is still worth noting that, based on the RegiSCAR score, this represents a probable, rather than a definitive, case of fenofibrate-associated DRESS syndrome.